Related Experiment Videos
[Central nervous system involvements in Duchenne/Becker muscular dystrophy]
1Aichi Welfare Center for Persons with Developmental Disabilities, Kasugai, Aichi.
No to Hattatsu = Brain and Development
|December 1, 2001
Summary
Duchenne/Becker muscular dystrophy (DMD/BMD) can cause mental retardation and autism. Deletions in the dystrophin gene, particularly near the 3' end, are linked to these central nervous system symptoms.
Area of Science:
- Neuromuscular Disorders
- Genetics
- Neurodevelopmental Disorders
Context:
- Duchenne/Becker muscular dystrophy (DMD/BMD) are common inherited muscle diseases due to dystrophin gene mutations.
- Recent findings link brain dystrophin abnormalities to mental retardation (MR).
Purpose:
- To investigate the relationship between molecular dystrophin gene abnormalities and central nervous system (CNS) phenotypes in DMD/BMD patients.
- To identify specific deletion regions associated with MR and autism in DMD/BMD.
Summary:
- Analyzed dystrophin gene deletions in 137 DMD/BMD patients (94 DMD, 43 BMD).
- Found 39% of DMD and 12% of BMD patients had MR; 8 DMD and 2 BMD patients had autism.
- MR/autism cases had deletions involving the 3' end of the dystrophin gene, suggesting C-terminal products (Dp140, Dp71, Dp116) involvement.
- Identified exceptions where similar mutations yielded different CNS phenotypes, indicating gene interactions.
Impact:
- Suggests C-terminal dystrophin products are implicated in MR and autism in DMD/BMD.
- Highlights that CNS phenotypes are not solely determined by dystrophin gene mutations.
- Underscores the potential role of interactions between dystrophin and other nuclear genes in CNS manifestations.